Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Other Accumulated Expenses (2018 - 2025)

Historic Other Accumulated Expenses for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $29.0 million.

  • AdaptHealth's Other Accumulated Expenses rose 1261.74% to $29.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.0 million, marking a year-over-year increase of 1261.74%. This contributed to the annual value of $26.5 million for FY2024, which is 14877.98% up from last year.
  • As of Q3 2025, AdaptHealth's Other Accumulated Expenses stood at $29.0 million, which was up 1261.74% from $28.9 million recorded in Q2 2025.
  • In the past 5 years, AdaptHealth's Other Accumulated Expenses registered a high of $108.3 million during Q1 2021, and its lowest value of $10.7 million during Q4 2023.
  • In the last 5 years, AdaptHealth's Other Accumulated Expenses had a median value of $26.9 million in 2022 and averaged $35.2 million.
  • Per our database at Business Quant, AdaptHealth's Other Accumulated Expenses surged by 55785.56% in 2021 and then plummeted by 6527.3% in 2022.
  • Quarter analysis of 5 years shows AdaptHealth's Other Accumulated Expenses stood at $43.2 million in 2021, then tumbled by 54.01% to $19.9 million in 2022, then tumbled by 46.36% to $10.7 million in 2023, then surged by 148.78% to $26.5 million in 2024, then rose by 9.44% to $29.0 million in 2025.
  • Its Other Accumulated Expenses was $29.0 million in Q3 2025, compared to $28.9 million in Q2 2025 and $30.7 million in Q1 2025.